世界のナノ構造薬物市場レポート2020年

【英語タイトル】Global Nanostructured Drug Sales Market Report 2020

QYResearchが出版した調査資料(QYR21FB9530)・商品コード:QYR21FB9530
・発行会社(調査会社):QYResearch
・発行日:2021年1月(※2024年版があります。お問い合わせください)
・ページ数:144
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
QYリサーチ社の本調査レポートでは、世界のナノ構造薬物市場について種類別(リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロ乳剤・ナノ乳剤、ナノ懸濁液)、用途別(癌・腫瘍、自己免疫疾患)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・ナノ構造薬物市場の概要
・世界の主要地域別ナノ構造薬物市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のナノ構造薬物市場規模2015-2026:種類別(リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロ乳剤・ナノ乳剤、ナノ懸濁液)
・世界のナノ構造薬物市場規模2015-2026:用途別(癌・腫瘍、自己免疫疾患)
・ナノ構造薬物のアメリカ市場規模2015-2020
・ナノ構造薬物のヨーロッパ市場規模2015-2020
・ナノ構造薬物の中国市場規模2015-2020
・ナノ構造薬物の日本市場規模2015-2020
・ナノ構造薬物の東南アジア市場規模2015-2020
・ナノ構造薬物のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・ナノ構造薬物の製造コスト分析
・販売チャネル、流通業者、顧客
・ナノ構造薬物の市場動向・機会・課題
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Nanostructured Drug Market
The global Nanostructured Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Nanostructured Drug Scope and Market Size
The global Nanostructured Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nanostructured Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Nanostructured Drug market is segmented into
Liposomes
Polymeric Micelles
Solid lipid Nanoparticles
Microemulsion and Nanoemulsion
Nanosuspension

Segment by Application, the Nanostructured Drug market is segmented into
Cancer and Tumors
Autoimmune Disorders

The Nanostructured Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Nanostructured Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Nanostructured Drug Market Share Analysis
Nanostructured Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nanostructured Drug business, the date to enter into the Nanostructured Drug market, Nanostructured Drug product introduction, recent developments, etc.

The major vendors covered:
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy

【レポートの目次】

1 Nanostructured Drug Market Overview
1.1 Nanostructured Drug Product Scope
1.2 Nanostructured Drug Segment by Type
1.2.1 Global Nanostructured Drug Sales by Type (2020-2026)
1.2.2 Liposomes
1.2.3 Polymeric Micelles
1.2.4 Solid lipid Nanoparticles
1.2.5 Microemulsion and Nanoemulsion
1.2.6 Nanosuspension
1.3 Nanostructured Drug Segment by Application
1.3.1 Global Nanostructured Drug Sales Comparison by Application (2020-2026)
1.3.2 Cancer and Tumors
1.3.3 Autoimmune Disorders
1.4 Nanostructured Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Nanostructured Drug Sales Growth Rate (2015-2026)
1.4.2 Global Nanostructured Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Nanostructured Drug Price Trends (2015-2026)

2 Nanostructured Drug Estimate and Forecast by Region
2.1 Global Nanostructured Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Nanostructured Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Nanostructured Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Nanostructured Drug Revenue Market Share by Region (2015-2020)
2.3 Global Nanostructured Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Nanostructured Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Nanostructured Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Nanostructured Drug Estimates and Projections (2015-2026)
2.4.2 Europe Nanostructured Drug Estimates and Projections (2015-2026)
2.4.3 China Nanostructured Drug Estimates and Projections (2015-2026)
2.4.4 Japan Nanostructured Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Nanostructured Drug Estimates and Projections (2015-2026)
2.4.6 India Nanostructured Drug Estimates and Projections (2015-2026)
3 Global Nanostructured Drug Competition Landscape by Players
3.1 Global Top Nanostructured Drug Players by Sales (2015-2020)
3.2 Global Top Nanostructured Drug Players by Revenue (2015-2020)
3.3 Global Nanostructured Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanostructured Drug as of 2019)
3.4 Global Nanostructured Drug Average Price by Company (2015-2020)
3.5 Manufacturers Nanostructured Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Nanostructured Drug Players (Opinion Leaders)
4 Global Nanostructured Drug Market Size by Type
4.1 Global Nanostructured Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Nanostructured Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Nanostructured Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Nanostructured Drug Price by Type (2015-2020)
4.2 Global Nanostructured Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Nanostructured Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Nanostructured Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Nanostructured Drug Price Forecast by Type (2021-2026)
5 Global Nanostructured Drug Market Size by Application
5.1 Global Nanostructured Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Nanostructured Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Nanostructured Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Nanostructured Drug Price by Application (2015-2020)
5.2 Global Nanostructured Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Nanostructured Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Nanostructured Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Nanostructured Drug Price Forecast by Application (2021-2026)

6 United States Nanostructured Drug Market Facts & Figures
6.1 United States Nanostructured Drug Sales Market Share by Company (2015-2020)
6.2 United States Nanostructured Drug Sales Market Share by Type (2015-2020)
6.3 United States Nanostructured Drug Sales Market Share by Application (2015-2020)

7 Europe Nanostructured Drug Market Facts & Figures
7.1 Europe Nanostructured Drug Sales Market Share by Company (2015-2020)
7.2 Europe Nanostructured Drug Sales Market Share by Type (2015-2020)
7.3 Europe Nanostructured Drug Sales Market Share by Application (2015-2020)

8 China Nanostructured Drug Market Facts & Figures
8.1 China Nanostructured Drug Sales Market Share by Company (2015-2020)
8.2 China Nanostructured Drug Sales Market Share by Type (2015-2020)
8.3 China Nanostructured Drug Sales Market Share by Application (2015-2020)

9 Japan Nanostructured Drug Market Facts & Figures
9.1 Japan Nanostructured Drug Sales Market Share by Company (3015-3030)
9.2 Japan Nanostructured Drug Sales Market Share by Type (2015-2020)
9.3 Japan Nanostructured Drug Sales Market Share by Application (2015-2020)

10 Southeast Asia Nanostructured Drug Market Facts & Figures
10.1 Southeast Asia Nanostructured Drug Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Nanostructured Drug Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Nanostructured Drug Sales Market Share by Application (2015-2020)

11 India Nanostructured Drug Market Facts & Figures
11.1 India Nanostructured Drug Sales Market Share by Company (2015-2020)
11.2 India Nanostructured Drug Sales Market Share by Type (2015-2020)
11.3 India Nanostructured Drug Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Nanostructured Drug Business
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Business Overview
12.1.3 Merck Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Nanostructured Drug Products Offered
12.1.5 Merck Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Business Overview
12.2.3 Pfizer Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Nanostructured Drug Products Offered
12.2.5 Pfizer Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Nanostructured Drug Products Offered
12.3.5 Novartis Recent Development
12.4 Abbott
12.4.1 Abbott Corporation Information
12.4.2 Abbott Business Overview
12.4.3 Abbott Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Abbott Nanostructured Drug Products Offered
12.4.5 Abbott Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Business Overview
12.5.3 GlaxoSmithKline Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GlaxoSmithKline Nanostructured Drug Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Roche
12.6.1 Roche Corporation Information
12.6.2 Roche Business Overview
12.6.3 Roche Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Roche Nanostructured Drug Products Offered
12.6.5 Roche Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Business Overview
12.7.3 Sanofi Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sanofi Nanostructured Drug Products Offered
12.7.5 Sanofi Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Corporation Information
12.8.2 Eli Lilly Business Overview
12.8.3 Eli Lilly Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Eli Lilly Nanostructured Drug Products Offered
12.8.5 Eli Lilly Recent Development
12.9 Astrazeneca
12.9.1 Astrazeneca Corporation Information
12.9.2 Astrazeneca Business Overview
12.9.3 Astrazeneca Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Astrazeneca Nanostructured Drug Products Offered
12.9.5 Astrazeneca Recent Development
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Corporation Information
12.10.2 Johnson & Johnson Business Overview
12.10.3 Johnson & Johnson Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Johnson & Johnson Nanostructured Drug Products Offered
12.10.5 Johnson & Johnson Recent Development
12.11 Celgene
12.11.1 Celgene Corporation Information
12.11.2 Celgene Business Overview
12.11.3 Celgene Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Celgene Nanostructured Drug Products Offered
12.11.5 Celgene Recent Development
12.12 Novavax
12.12.1 Novavax Corporation Information
12.12.2 Novavax Business Overview
12.12.3 Novavax Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Novavax Nanostructured Drug Products Offered
12.12.5 Novavax Recent Development
12.13 Stryker
12.13.1 Stryker Corporation Information
12.13.2 Stryker Business Overview
12.13.3 Stryker Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Stryker Nanostructured Drug Products Offered
12.13.5 Stryker Recent Development
12.14 Gilead Sciences
12.14.1 Gilead Sciences Corporation Information
12.14.2 Gilead Sciences Business Overview
12.14.3 Gilead Sciences Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Gilead Sciences Nanostructured Drug Products Offered
12.14.5 Gilead Sciences Recent Development
12.15 OSI Pharmaceuticals
12.15.1 OSI Pharmaceuticals Corporation Information
12.15.2 OSI Pharmaceuticals Business Overview
12.15.3 OSI Pharmaceuticals Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.15.4 OSI Pharmaceuticals Nanostructured Drug Products Offered
12.15.5 OSI Pharmaceuticals Recent Development
12.16 Kadmon Pharmaceuticals
12.16.1 Kadmon Pharmaceuticals Corporation Information
12.16.2 Kadmon Pharmaceuticals Business Overview
12.16.3 Kadmon Pharmaceuticals Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Kadmon Pharmaceuticals Nanostructured Drug Products Offered
12.16.5 Kadmon Pharmaceuticals Recent Development
12.17 Samyang Biopharm
12.17.1 Samyang Biopharm Corporation Information
12.17.2 Samyang Biopharm Business Overview
12.17.3 Samyang Biopharm Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Samyang Biopharm Nanostructured Drug Products Offered
12.17.5 Samyang Biopharm Recent Development
12.18 Mitsubishi Pharma
12.18.1 Mitsubishi Pharma Corporation Information
12.18.2 Mitsubishi Pharma Business Overview
12.18.3 Mitsubishi Pharma Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Mitsubishi Pharma Nanostructured Drug Products Offered
12.18.5 Mitsubishi Pharma Recent Development
12.19 Kaken Pharmaceutical
12.19.1 Kaken Pharmaceutical Corporation Information
12.19.2 Kaken Pharmaceutical Business Overview
12.19.3 Kaken Pharmaceutical Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Kaken Pharmaceutical Nanostructured Drug Products Offered
12.19.5 Kaken Pharmaceutical Recent Development
12.20 Selecta Biosciences
12.20.1 Selecta Biosciences Corporation Information
12.20.2 Selecta Biosciences Business Overview
12.20.3 Selecta Biosciences Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Selecta Biosciences Nanostructured Drug Products Offered
12.20.5 Selecta Biosciences Recent Development
12.21 Par Pharmaceutical
12.21.1 Par Pharmaceutical Corporation Information
12.21.2 Par Pharmaceutical Business Overview
12.21.3 Par Pharmaceutical Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Par Pharmaceutical Nanostructured Drug Products Offered
12.21.5 Par Pharmaceutical Recent Development
12.22 Cerulean Pharma
12.22.1 Cerulean Pharma Corporation Information
12.22.2 Cerulean Pharma Business Overview
12.22.3 Cerulean Pharma Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Cerulean Pharma Nanostructured Drug Products Offered
12.22.5 Cerulean Pharma Recent Development
12.23 Navidea Biopharmaceuticals
12.23.1 Navidea Biopharmaceuticals Corporation Information
12.23.2 Navidea Biopharmaceuticals Business Overview
12.23.3 Navidea Biopharmaceuticals Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Navidea Biopharmaceuticals Nanostructured Drug Products Offered
12.23.5 Navidea Biopharmaceuticals Recent Development
12.24 Lummy
12.24.1 Lummy Corporation Information
12.24.2 Lummy Business Overview
12.24.3 Lummy Nanostructured Drug Sales, Revenue and Gross Margin (2015-2020)
12.24.4 Lummy Nanostructured Drug Products Offered
12.24.5 Lummy Recent Development

13 Nanostructured Drug Manufacturing Cost Analysis
13.1 Nanostructured Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Nanostructured Drug
13.4 Nanostructured Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Nanostructured Drug Distributors List
14.3 Nanostructured Drug Customers

15 Market Dynamics
15.1 Nanostructured Drug Market Trends
15.2 Nanostructured Drug Opportunities and Drivers
15.3 Nanostructured Drug Market Challenges
15.4 Nanostructured Drug Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Nanostructured Drug Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Nanostructured Drug Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Nanostructured Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Nanostructured Drug Sales (K MT) by Region (2015-2020)
Table 5. Global Nanostructured Drug Sales Market Share by Region (2015-2020)
Table 6. Global Nanostructured Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Nanostructured Drug Revenue Share by Region (2015-2020)
Table 8. Global Nanostructured Drug Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Nanostructured Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Nanostructured Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Nanostructured Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Nanostructured Drug (K MT) of Key Companies (2015-2020)
Table 13. Global Nanostructured Drug Sales Share by Company (2015-2020)
Table 14. Global Nanostructured Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Nanostructured Drug Revenue Share by Company (2015-2020)
Table 16. Global Nanostructured Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanostructured Drug as of 2019)
Table 17. Global Nanostructured Drug Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Nanostructured Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Nanostructured Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Nanostructured Drug Players
Table 22. Global Nanostructured Drug Sales (K MT) by Type (2015-2020)
Table 23. Global Nanostructured Drug Sales Share by Type (2015-2020)
Table 24. Global Nanostructured Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Nanostructured Drug Price (K MT) by Type (2015-2020)
Table 26. Global Nanostructured Drug Sales Share by Type (2021-2026)
Table 27. Global Nanostructured Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Nanostructured Drug Revenue Share by Type (2021-2026)
Table 29. Global Nanostructured Drug Price (K MT) by Type (2021-2026)
Table 30. Global Nanostructured Drug Sales (K MT) by Application (2015-2020)
Table 31. Global Nanostructured Drug Sales Share by Application (2015-2020)
Table 32. Global Nanostructured Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Nanostructured Drug Price (K MT) by Application (2015-2020)
Table 34. Global Nanostructured Drug Sales (K MT) by Application (2021-2026)
Table 35. Global Nanostructured Drug Sales Share by Application (2021-2026)
Table 36. Global Nanostructured Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Nanostructured Drug Revenue Share by Application (2021-2026)
Table 38. Global Nanostructured Drug Price (K MT) by Application (2021-2026)
Table 39. United States Nanostructured Drug Sales (K MT) by Company (2015-2020)
Table 40. United States Nanostructured Drug Sales Market Share by Company (2015-2020)
Table 41. United States Nanostructured Drug Sales (K MT) by Type (2015-2020)
Table 42. United States Nanostructured Drug Sales Market Share by Type (2015-2020)
Table 43. United States Nanostructured Drug Sales (K MT) by Application (2015-2020)
Table 44. United States Nanostructured Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Nanostructured Drug Sales (K MT) by Company (2015-2020)
Table 46. Europe Nanostructured Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Nanostructured Drug Sales (K MT) by Type (2015-2020)
Table 48. Europe Nanostructured Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Nanostructured Drug Sales (K MT) by Application (2015-2020)
Table 50. Europe Nanostructured Drug Sales Market Share by Type (2015-2020)
Table 51. China Nanostructured Drug Sales (K MT) by Company (2015-2020)
Table 52. China Nanostructured Drug Sales Market Share by Company (2015-2020)
Table 53. China Nanostructured Drug Sales (K MT) by Type (2015-2020)
Table 54. China Nanostructured Drug Sales Market Share by Type (2015-2020)
Table 55. China Nanostructured Drug Sales (K MT) by Application (2015-2020)
Table 56. China Nanostructured Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Nanostructured Drug Sales (K MT) by Company (2015-2020)
Table 58. Japan Nanostructured Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Nanostructured Drug Sales (K MT) by Type (2015-2020)
Table 60. Japan Nanostructured Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Nanostructured Drug Sales (K MT) by Application (2015-2020)
Table 62. Japan Nanostructured Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Nanostructured Drug Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Nanostructured Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Nanostructured Drug Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Nanostructured Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Nanostructured Drug Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Nanostructured Drug Sales Market Share by Application (2015-2020)
Table 69. India Nanostructured Drug Sales (K MT) by Company (2015-2020)
Table 70. India Nanostructured Drug Sales Market Share by Company (2015-2020)
Table 71. India Nanostructured Drug Sales (K MT) by Type (2015-2020)
Table 72. India Nanostructured Drug Sales Market Share by Type (2015-2020)
Table 73. India Nanostructured Drug Sales (K MT) by Application (2015-2020)
Table 74. India Nanostructured Drug Sales Market Share by Application (2015-2020)
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Merck Nanostructured Drug Product
Table 79. Merck Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Pfizer Nanostructured Drug Product
Table 84. Pfizer Recent Development
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Novartis Nanostructured Drug Product
Table 89. Novartis Recent Development
Table 90. Abbott Corporation Information
Table 91. Abbott Description and Business Overview
Table 92. Abbott Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Abbott Nanostructured Drug Product
Table 94. Abbott Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Nanostructured Drug Product
Table 99. GlaxoSmithKline Recent Development
Table 100. Roche Corporation Information
Table 101. Roche Description and Business Overview
Table 102. Roche Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Roche Nanostructured Drug Product
Table 104. Roche Recent Development
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Sanofi Nanostructured Drug Product
Table 109. Sanofi Recent Development
Table 110. Eli Lilly Corporation Information
Table 111. Eli Lilly Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Eli Lilly Description and Business Overview
Table 113. Eli Lilly Nanostructured Drug Product
Table 114. Eli Lilly Recent Development
Table 115. Astrazeneca Corporation Information
Table 116. Astrazeneca Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Astrazeneca Description and Business Overview
Table 118. Astrazeneca Nanostructured Drug Product
Table 119. Astrazeneca Recent Development
Table 120. Johnson & Johnson Corporation Information
Table 121. Johnson & Johnson Description and Business Overview
Table 122. Johnson & Johnson Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Johnson & Johnson Nanostructured Drug Product
Table 124. Johnson & Johnson Recent Development
Table 125. Celgene Corporation Information
Table 126. Celgene Description and Business Overview
Table 127. Celgene Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Celgene Nanostructured Drug Product
Table 129. Celgene Recent Development
Table 130. Novavax Corporation Information
Table 131. Novavax Description and Business Overview
Table 132. Novavax Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Novavax Nanostructured Drug Product
Table 134. Novavax Recent Development
Table 135. Stryker Corporation Information
Table 136. Stryker Description and Business Overview
Table 137. Stryker Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Stryker Nanostructured Drug Product
Table 139. Stryker Recent Development
Table 140. Gilead Sciences Corporation Information
Table 141. Gilead Sciences Description and Business Overview
Table 142. Gilead Sciences Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Gilead Sciences Nanostructured Drug Product
Table 144. Gilead Sciences Recent Development
Table 145. OSI Pharmaceuticals Corporation Information
Table 146. OSI Pharmaceuticals Description and Business Overview
Table 147. OSI Pharmaceuticals Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. OSI Pharmaceuticals Nanostructured Drug Product
Table 149. OSI Pharmaceuticals Recent Development
Table 150. Kadmon Pharmaceuticals Corporation Information
Table 151. Kadmon Pharmaceuticals Description and Business Overview
Table 152. Kadmon Pharmaceuticals Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Kadmon Pharmaceuticals Nanostructured Drug Product
Table 154. Kadmon Pharmaceuticals Recent Development
Table 155. Samyang Biopharm Corporation Information
Table 156. Samyang Biopharm Description and Business Overview
Table 157. Samyang Biopharm Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Samyang Biopharm Nanostructured Drug Product
Table 159. Samyang Biopharm Recent Development
Table 160. Mitsubishi Pharma Corporation Information
Table 161. Mitsubishi Pharma Description and Business Overview
Table 162. Mitsubishi Pharma Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. Mitsubishi Pharma Nanostructured Drug Product
Table 164. Mitsubishi Pharma Recent Development
Table 165. Kaken Pharmaceutical Corporation Information
Table 166. Kaken Pharmaceutical Description and Business Overview
Table 167. Kaken Pharmaceutical Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Kaken Pharmaceutical Nanostructured Drug Product
Table 169. Kaken Pharmaceutical Recent Development
Table 170. Selecta Biosciences Corporation Information
Table 171. Selecta Biosciences Description and Business Overview
Table 172. Selecta Biosciences Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 173. Selecta Biosciences Nanostructured Drug Product
Table 174. Selecta Biosciences Recent Development
Table 175. Par Pharmaceutical Corporation Information
Table 176. Par Pharmaceutical Description and Business Overview
Table 177. Par Pharmaceutical Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 178. Par Pharmaceutical Nanostructured Drug Product
Table 179. Par Pharmaceutical Recent Development
Table 180. Cerulean Pharma Corporation Information
Table 181. Cerulean Pharma Description and Business Overview
Table 182. Cerulean Pharma Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 183. Cerulean Pharma Nanostructured Drug Product
Table 184. Cerulean Pharma Recent Development
Table 185. Navidea Biopharmaceuticals Corporation Information
Table 186. Navidea Biopharmaceuticals Description and Business Overview
Table 187. Navidea Biopharmaceuticals Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 188. Navidea Biopharmaceuticals Nanostructured Drug Product
Table 189. Navidea Biopharmaceuticals Recent Development
Table 190. Lummy Corporation Information
Table 191. Lummy Description and Business Overview
Table 192. Lummy Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 193. Lummy Nanostructured Drug Product
Table 194. Lummy Recent Development
Table 195. Production Base and Market Concentration Rate of Raw Material
Table 196. Key Suppliers of Raw Materials
Table 197. Nanostructured Drug Distributors List
Table 198. Nanostructured Drug Customers List
Table 199. Nanostructured Drug Market Key Trends
Table 200. Nanostructured Drug Key Opportunities and Drivers
Table 201. Nanostructured Drug Market Challenges
Table 202. Research Programs/Design for This Report
Table 203. Key Data Information from Secondary Sources
Table 204. Key Data Information from Primary Sources
List of Figures
Figure 1. Nanostructured Drug Product Picture
Figure 2. Global Nanostructured Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Nanostructured Drug Market Share by Application in 2020 & 2026
Figure 6. Cancer and Tumors Examples
Figure 7. Autoimmune Disorders Examples
Figure 8. Global Nanostructured Drug Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Nanostructured Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Nanostructured Drug Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Nanostructured Drug Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Nanostructured Drug Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Nanostructured Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Nanostructured Drug Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Nanostructured Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Nanostructured Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Nanostructured Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Nanostructured Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Nanostructured Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Nanostructured Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Nanostructured Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Nanostructured Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Nanostructured Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Nanostructured Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Nanostructured Drug Players Market Share by Revenue in Nanostructured Drug 2015 & 2019
Figure 26. Nanostructured Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Nanostructured Drug Revenue Share by Type (2015-2020)
Figure 28. Global Nanostructured Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Nanostructured Drug Revenue Share by Application (2015-2020)
Figure 30. Global Nanostructured Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Nanostructured Drug Sales Market Share by Type in 2019
Figure 32. United States Nanostructured Drug Sales Market Share by Type in 2019
Figure 33. Europe Nanostructured Drug Sales Market Share by Company in 2019
Figure 34. Europe Nanostructured Drug Sales Market Share by Type in 2019
Figure 35. Europe Nanostructured Drug Sales Market Share by Application in 2019
Figure 36. China Nanostructured Drug Sales Market Share by Company in 2019
Figure 37. China Nanostructured Drug Sales Market Share by Type in 2019
Figure 38. China Nanostructured Drug Sales Market Share by Application in 2019
Figure 39. Japan Nanostructured Drug Sales Market Share by Company in 2019
Figure 40. Japan Nanostructured Drug Sales Market Share by Type in 2019
Figure 41. Japan Nanostructured Drug Sales Market Share by Application in 2019
Figure 42. Southeast Asia Nanostructured Drug Sales Market Share by Company in 2019
Figure 43. Southeast Asia Nanostructured Drug Sales Market Share by Type in 2019
Figure 44. Southeast Asia Nanostructured Drug Sales Market Share by Application in 2019
Figure 45. India Nanostructured Drug Sales Market Share by Company in 2019
Figure 46. India Nanostructured Drug Sales Market Share by Type in 2019
Figure 47. India Nanostructured Drug Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Nanostructured Drug
Figure 50. Manufacturing Process Analysis of Nanostructured Drug
Figure 51. Nanostructured Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed


【掲載企業】

Merck、Pfizer、Novartis、Abbott、GlaxoSmithKline、Roche、Sanofi、Eli Lilly、Astrazeneca、Johnson & Johnson、Celgene、Novavax、Stryker、Gilead Sciences、OSI Pharmaceuticals、Kadmon Pharmaceuticals、Samyang Biopharm、Mitsubishi Pharma、Kaken Pharmaceutical、Selecta Biosciences、Par Pharmaceutical、Cerulean Pharma、Navidea Biopharmaceuticals、Lummy

★調査レポート[世界のナノ構造薬物市場レポート2020年] (コード:QYR21FB9530)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のナノ構造薬物市場レポート2020年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆